Dr. Reddy's Laboratories Ltd (RDY) vs Teva Pharmaceutical Industries Ltd. (TEVA)
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
- Teva Pharmaceutical Industries Ltd. TEVA 41.52 +1.00%
Dr. Reddy's Laboratories Ltd and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $47.9B against $10.7B — 4.5× the size. Dr. Reddy's Laboratories Ltd trades at the lower P/E: 32.9× against 65.9×. Teva Pharmaceutical Industries Ltd. grew revenue faster over the last twelve months: 4.13% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs 4.08%) and the higher return on invested capital (5.89% vs 4.58%). Across the 22 metrics below, Dr. Reddy's Laboratories Ltd leads on 14 and Teva Pharmaceutical Industries Ltd. on 8.
Valuation
Profitability
| Metric | RDY | TEVA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 50.00% | 52.46% | 53.94% |
| Operating margin | 10.91% | 8.77% | 0.00% |
| Net margin | 9.81% | 4.08% | 0.00% |
| Free cash flow margin | 4.05% | 8.09% | 0.00% |
| Return on equity | 8.21% | 9.69% | (0.40%) |
| Return on assets | 5.55% | 1.77% | (3.32%) |
| Return on invested capital | 5.89% | 4.58% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack